DecisionPoint Financial’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$352 Buy
3
+1
+50% +$115 ﹤0.01% 757
2026
Q1
$239 Hold
2
﹤0.01% 604
2025
Q4
$273 Hold
2
﹤0.01% 641
2025
Q3
$296 Sell
2
-750
-100% -$104K ﹤0.01% 572
2025
Q2
$98.5K Buy
752
+2
+0.3% +$242 0.03% 60
2025
Q1
$89.6K Hold
750
0.03% 61
2024
Q4
$87K Hold
750
0.03% 60
2024
Q3
$101K Hold
750
0.03% 57
2024
Q2
$100K Hold
750
0.03% 55
2024
Q1
$99.3K Hold
750
0.04% 51
2023
Q4
$85.8K Hold
750
0.04% 50
2023
Q3
$68.3K Hold
750
0.04% 51
2023
Q2
$84.5K Hold
750
0.04% 43
2023
Q1
$78.5K Hold
750
0.05% 45
2022
Q4
$82.9K Buy
+750
New +$78.6K 0.05% 38

Other funds holding XYL

DecisionPoint Financial's XYL Position: Q2 2026 in Review

DecisionPoint Financial increased its Xylem (XYL) stake by 50% in Q2 2026, buying an estimated $115 and bringing the position to 3 shares worth $352. The position accounts for ﹤0.01% of the portfolio, ranked #757.

DecisionPoint Financial first reported a position in XYL in Q4 2022 and has held it in 15 quarters since. The position peaked at $101K in Q3 2024. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • DecisionPoint Financial held 3 shares of Xylem worth $352 as of Q2 2026.
  • DecisionPoint Financial bought 1 Xylem share in Q2 2026, an estimated $115.
  • Xylem made up ﹤0.01% of DecisionPoint Financial's portfolio in Q2 2026, its #757 holding.
  • DecisionPoint Financial first reported a position in Xylem in Q4 2022 and has held it in 15 quarters since.
  • DecisionPoint Financial's Xylem position peaked at $101K in Q3 2024.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on DecisionPoint Financial's 13F filing for Q2 2026, filed 5 Aug 2026.